NVS
Novartis AG$147.13
-0.36%LiveJun 18, 2026
Market cap
$280.74B
52w range
112.34 – 170.46
P / E
—
EPS
—
Volume
309.08K
Revenue · FY
—
Explain this page
Arphra AIPlain-English read on Novartis AG’s valuationConsensus target
$141.00-4.2%
$112$170
Low $112Median $141High $170
Rating distribution
No rating distribution on file.
Composite rating
B+
Score 3/5
Consensus
—
Target consensus
$141.00
-4.17% vs spot
Recent activity
1 ratings
Last 30 days
Ratings snapshot
DB · ratings_historyJun 08, 2026Composite
B+
3/5 score
Components (1-5)
- Discounted CF4
- Return on equity5
- Return on assets5
- Debt / equity1
- Price / earnings2
- Price / book1
No grades consensus available.
Price target · summary
DB · price_targets_historyJun 08, 2026Last month
$141.00
1 snapshots-4.17%
Last quarter
$141.00
1 snapshots-4.17%
Last year
$141.00
1 snapshots-4.17%
All-time
$141.00
1 snapshots-4.17%
Low
$112.00
-23.88% vs spot
Median
$141.00
-4.17% vs spot
High
$170.00
+15.54% vs spot
Estimate revisions · forward years
DBSell-side consensus EPS / Revenue / EBITDA over time, per forward fiscal year.
2026-12-31
1 snapshots
EPS—
Revenue ($B)—
2027-12-31
1 snapshots
EPS—
Revenue ($B)—
2028-12-31
1 snapshots
EPS—
Revenue ($B)—
Peer comparables
Green = best, red = worst (per column)| Ticker | Mcap | P/E | P/S | EV/EBITDA | ROE | D/E | Div Yield |
|---|---|---|---|---|---|---|---|
NVSNovartis AGFocus | 288.34B | — | — | — | — | — | — |
Analyst grade actions — 5 years
Stacked monthly countsNo analyst-grade actions in
analyst_grades for NVS over the last 5 years.Historical ratings
DB · ratings_history1| Date | Composite | Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| Jun 08, 2026 | B+ | 3 | 4 | 5 | 5 | 1 | 2 | 1 |